ArticleHeliyon2023

Hematological, inflammatory, and novel biomarkers assessment as an eminent strategy for clinical management of COVID-19.

Sanaz Rezaeian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.